Cargando…

Resectable pancreatic small cell carcinoma

Primary pancreatic small cell carcinoma (SCC) is rare, with just over 30 cases reported in the literature. Only 7 of these patients underwent surgical resection with a median survival of 6 months. Prognosis of SCC is therefore considered to be poor, and the role of adjuvant therapy is uncertain. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winter, Jordan M., Narang, Amol K., Mansfield, Aaron S., Herman, Joseph M., Cameron, John L., Laheru, Dan, Eckhauser, Fred E., Olson, Mathew T., Hruban, Ralph H., Miller, Robert C., Andersen, Dana K.
Formato:	Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070453/ https://www.ncbi.nlm.nih.gov/pubmed/21464878 http://dx.doi.org/10.4081/rt.2011.e5

Ejemplares similares

Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer
por: Gemenetzis, Georgios, et al.
Publicado: (2021)

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers
por: Schunke, Kathryn J., et al.
Publicado: (2017)

Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study
por: Narang, Amol K, et al.
Publicado: (2011)

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer
por: Shrestha, Bikram, et al.
Publicado: (2017)

Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns
por: Wangjam, Tamna, et al.
Publicado: (2015)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
por: Reddy, Abhinav V., et al.
Publicado: (2022)

A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review
por: Rosati, Lauren M., et al.
Publicado: (2017)

Intraductal Pancreatic Cancer is Less Responsive Than Cancer in the Stroma to Neoadjuvant Chemotherapy
por: Fujikura, Kohei, et al.
Publicado: (2020)

Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas
por: Hong, Seung-Mo, et al.
Publicado: (2011)

Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
por: Reddy, Abhinav V., et al.
Publicado: (2021)

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
por: Hill, Colin, et al.
Publicado: (2022)

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
por: Dal Molin, Marco, et al.
Publicado: (2016)

The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer
por: Lin, Timothy, et al.
Publicado: (2023)

Commentary: Go out on a limb, that's where the fruit is!
por: Eckhauser, Aaron
Publicado: (2020)

Genomic Landscapes of Pancreatic Neoplasia
por: Wood, Laura D., et al.
Publicado: (2015)

The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience
por: Javed, Ammar A., et al.
Publicado: (2022)

Mesothelin-specific CD8(+) T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients
por: Thomas, Amy Morck, et al.
Publicado: (2004)

Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study
por: Hsu, Charles C., et al.
Publicado: (2010)

A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
por: Viúdez, Antonio, et al.
Publicado: (2016)

Correction: A new immunohistochemistry prognostic score (IPS) for recurrence and survival in resected pancreatic neuroendocrine tumors (PanNET)
por: Viúdez, Antonio, et al.
Publicado: (2017)

Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
por: Hill, Colin S., et al.
Publicado: (2021)

Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature
por: Reddy, Abhinav V., et al.
Publicado: (2022)

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
por: Cheng, Zhi, et al.
Publicado: (2018)

Surgical and molecular pathology of pancreatic neoplasms
por: Hackeng, Wenzel M., et al.
Publicado: (2016)

Adult Pancreatic Hemangioma: Case Report and Literature Review
por: Mundinger, Gerhard S., et al.
Publicado: (2009)

Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment
por: Herman, Joseph M., et al.
Publicado: (2019)

Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
por: Reddy, Abhinav V., et al.
Publicado: (2021)

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
por: Heumann, Thatcher, et al.
Publicado: (2023)

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study
por: Gupta, Amol, et al.
Publicado: (2023)

Autoimmune Pancreatitis Accompanied by Cholecystitis, Periaortitis and Pseudotumors of the Liver
por: Matsubayashi, Hiroyuki, et al.
Publicado: (2008)

Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
por: Ottenhof, Niki A., et al.
Publicado: (2011)

Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression
por: Hutchings, Danielle, et al.
Publicado: (2018)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial
por: Reddy, Abhinav V., et al.
Publicado: (2022)

Importance of Age of Onset in Pancreatic Cancer Kindreds
por: Brune, Kieran A., et al.
Publicado: (2010)

Phosphodiesterase 5 Inhibition Improves β-Cell Function in Metabolic Syndrome
por: Hill, Kevin D., et al.
Publicado: (2009)

A systematic method for using 3D echocardiography to evaluate tricuspid valve insufficiency in hypoplastic left heart syndrome
por: Mart, Christopher Robin, et al.
Publicado: (2014)

Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer
por: Shindo, Koji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mhid72l64fd70t1gh449aov1jn